Myriad Genetics, Inc. (MYGN) free cash flow

Free cash flow · fiscal 2025
-$25.60M

Myriad Genetics, Inc. (MYGN) generated free cash flow of -$25.60M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$38.40M. Figures as of 18 Nov 2026, 12:41 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
-$25.60M
Highest on record
$175.90Mfiscal 2014
Lowest on record
-$184.20Mfiscal 2023
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Myriad Genetics, Inc. free cash flow, in more detail

Across the 17 fiscal years on record (2009–2025), the highest was $175.90M in fiscal 2014 and the lowest -$184.20M in fiscal 2023.

History · 17 fiscal years

Free cash flow by fiscal year

Myriad Genetics, Inc. free cash flow, year by year

Myriad Genetics, Inc. (MYGN) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025-$25.60M—
2024-$38.40M—
2023-$184.20M—
2022-$151.60M 25,366.7% down
2021$600.00K 98.8% down
2020$50.50M 32.8% down
2019$75.10M 30.1% down
2018$107.50M 7.4% up
2017$100.10M 37.9% down
2016$161.30M 38.3% up
2015$116.60M 33.7% down
2014$175.90M 8.3% up
2013$162.47M 22.7% up
2012$132.40M 4.2% up
2011$127.04M 13.7% down
2010$147.19M 92.4% up
2009$76.52M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

More on MYGN

Myriad Genetics, Inc., figure by figure

Myriad Genetics, Inc. (MYGN) overview: price, valuation and scorecard

Myriad Genetics, Inc. free cash flow: questions and answers

What is Myriad Genetics, Inc.'s free cash flow?

Myriad Genetics, Inc. (MYGN) generated free cash flow of -$25.60M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$38.40M.

What are the highest and lowest free cash flow figures on record for Myriad Genetics, Inc.?

Across the 17 fiscal years on record (2009–2025), the highest was $175.90M in fiscal 2014 and the lowest -$184.20M in fiscal 2023.

How is Myriad Genetics, Inc.'s free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Myriad Genetics, Inc. it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Myriad Genetics, Inc. (MYGN) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/MYGN/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.